{"entity":{"type":"insider","cik":"0001867899","url":"/insider/0001867899","json_url":"/insider/0001867899.json","name":"Tessari Eben","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":24,"first":"2024-03-05","last":"2025-12-17","span_basis":"filed_date"},"name_variants":[{"name":"Tessari Eben","source":"filing","n_filings":24,"first_seen":"2024-03-05","last_seen":"2025-12-17"}],"transactions":[{"id":4397251,"accession":"0001867899-25-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001867899-25-000013","line_url":"/filing/0001867899-25-000013#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12048.0,"shares_display":"12,048","price_per_share":41.56,"price_display":"41.56","price_state":"stated","total_value":500714.88,"total_display":"500,714.88","total_whole":"500,715","shares_owned_after":16666.0,"shares_owned_after_display":"16,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-17","scope":"insider"},{"id":4779945,"accession":"0001867899-25-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001867899-25-000011","line_url":"/filing/0001867899-25-000011#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":42.89,"price_display":"42.89","price_state":"stated","total_value":8578.0,"total_display":"8,578.00","total_whole":"8,578","shares_owned_after":22714.0,"shares_owned_after_display":"22,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-12-01","scope":"insider"},{"id":5100791,"accession":"0001867899-25-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001867899-25-000009","line_url":"/filing/0001867899-25-000009","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12470.0,"shares_display":"12,470","price_per_share":41.236896551724136,"price_display":"41.24","price_state":"stated","total_value":514224.1,"total_display":"514,224.10","total_whole":"514,224","shares_owned_after":22714.0,"shares_owned_after_display":"22,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider","n_lines":2},{"id":4518057,"accession":"0001867899-25-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001867899-25-000007","line_url":"/filing/0001867899-25-000007","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12368.0,"shares_display":"12,368","price_per_share":37.66520213454075,"price_display":"37.67","price_state":"stated","total_value":465843.22,"total_display":"465,843.22","total_whole":"465,843","shares_owned_after":29237.0,"shares_owned_after_display":"29,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-14","filed_date":"2025-10-16","scope":"insider","n_lines":2},{"id":4686689,"accession":"0001867899-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001867899-25-000005","line_url":"/filing/0001867899-25-000005#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42000.0,"shares_display":"42,000","price_per_share":38.33,"price_display":"38.33","price_state":"stated","total_value":1609860.0,"total_display":"1,609,860.00","total_whole":"1,609,860","shares_owned_after":34552.0,"shares_owned_after_display":"34,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider"},{"id":5061948,"accession":"0001867899-25-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001867899-25-000003","line_url":"/filing/0001867899-25-000003","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16400.0,"shares_display":"16,400","price_per_share":36.46193902439025,"price_display":"36.46","price_state":"stated","total_value":597975.8,"total_display":"597,975.80","total_whole":"597,976","shares_owned_after":34908.0,"shares_owned_after_display":"34,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-17","scope":"insider","n_lines":2},{"id":4212131,"accession":"0001415889-25-023878","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-023878","line_url":"/filing/0001415889-25-023878#line-5","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13389.0,"shares_display":"13,389","price_per_share":35.66,"price_display":"35.66","price_state":"stated","total_value":477451.74,"total_display":"477,451.74","total_whole":"477,452","shares_owned_after":44452.0,"shares_owned_after_display":"44,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-08","scope":"insider"},{"id":4212122,"accession":"0001415889-25-023878","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-023878","line_url":"/filing/0001415889-25-023878#line-3","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85271.0,"shares_display":"85,271","price_per_share":35.52,"price_display":"35.52","price_state":"stated","total_value":3028825.92,"total_display":"3,028,825.92","total_whole":"3,028,826","shares_owned_after":44452.0,"shares_owned_after_display":"44,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider"},{"id":4807186,"accession":"0001415889-25-023587","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001415889-25-023587","line_url":"/filing/0001415889-25-023587#line-9","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15091.0,"shares_display":"15,091","price_per_share":35.5,"price_display":"35.50","price_state":"stated","total_value":535730.5,"total_display":"535,730.50","total_whole":"535,731","shares_owned_after":44452.0,"shares_owned_after_display":"44,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-03","scope":"insider"},{"id":4862477,"accession":"0001415889-25-022460","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-022460","line_url":"/filing/0001415889-25-022460","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16200.0,"shares_display":"16,200","price_per_share":33.77413580246913,"price_display":"33.77","price_state":"stated","total_value":547141.0,"total_display":"547,141.00","total_whole":"547,141","shares_owned_after":40315.0,"shares_owned_after_display":"40,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider","n_lines":2},{"id":5081375,"accession":"0001415889-25-021271","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-25-021271","line_url":"/filing/0001415889-25-021271","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138614.0,"shares_display":"138,614","price_per_share":33.202777497222506,"price_display":"33.20","price_state":"stated","total_value":4602369.8,"total_display":"4,602,369.80","total_whole":"4,602,370","shares_owned_after":50465.0,"shares_owned_after_display":"50,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-05","filed_date":"2025-08-07","scope":"insider","n_lines":2},{"id":5040143,"accession":"0001415889-25-019841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-019841","line_url":"/filing/0001415889-25-019841#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18900.0,"shares_display":"18,900","price_per_share":28.72,"price_display":"28.72","price_state":"stated","total_value":542808.0,"total_display":"542,808.00","total_whole":"542,808","shares_owned_after":49163.0,"shares_owned_after_display":"49,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-16","scope":"insider"},{"id":4358491,"accession":"0001415889-25-017691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-017691","line_url":"/filing/0001415889-25-017691#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17300.0,"shares_display":"17,300","price_per_share":28.28,"price_display":"28.28","price_state":"stated","total_value":489244.0,"total_display":"489,244.00","total_whole":"489,244","shares_owned_after":61563.0,"shares_owned_after_display":"61,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":4433983,"accession":"0001415889-25-016722","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-25-016722","line_url":"/filing/0001415889-25-016722#line-6","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45042.0,"shares_display":"45,042","price_per_share":30.51,"price_display":"30.51","price_state":"stated","total_value":1374231.42,"total_display":"1,374,231.42","total_whole":"1,374,231","shares_owned_after":72363.0,"shares_owned_after_display":"72,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-11","filed_date":"2025-06-11","scope":"insider"},{"id":4433977,"accession":"0001415889-25-016722","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-016722","line_url":"/filing/0001415889-25-016722#line-4","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15506.0,"shares_display":"15,506","price_per_share":30.46,"price_display":"30.46","price_state":"stated","total_value":472312.76,"total_display":"472,312.76","total_whole":"472,313","shares_owned_after":72363.0,"shares_owned_after_display":"72,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-11","scope":"insider"},{"id":4433971,"accession":"0001415889-25-016722","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-016722","line_url":"/filing/0001415889-25-016722#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10319.0,"shares_display":"10,319","price_per_share":30.38,"price_display":"30.38","price_state":"stated","total_value":313491.22,"total_display":"313,491.22","total_whole":"313,491","shares_owned_after":72363.0,"shares_owned_after_display":"72,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-11","scope":"insider"},{"id":4211439,"accession":"0001415889-25-013944","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-013944","line_url":"/filing/0001415889-25-013944#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":26.41,"price_display":"26.41","price_state":"stated","total_value":316920.0,"total_display":"316,920.00","total_whole":"316,920","shares_owned_after":72363.0,"shares_owned_after_display":"72,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-21","scope":"insider"},{"id":5154087,"accession":"0001415889-25-010808","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-010808","line_url":"/filing/0001415889-25-010808","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":20.484295833333334,"price_display":"20.48","price_state":"stated","total_value":245811.55,"total_display":"245,811.55","total_whole":"245,812","shares_owned_after":77363.0,"shares_owned_after_display":"77,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-14","filed_date":"2025-04-16","scope":"insider","n_lines":2},{"id":4805763,"accession":"0001415889-25-007814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-007814","line_url":"/filing/0001415889-25-007814#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12409.0,"shares_display":"12,409","price_per_share":21.06,"price_display":"21.06","price_state":"stated","total_value":261333.54,"total_display":"261,333.54","total_whole":"261,334","shares_owned_after":76566.0,"shares_owned_after_display":"76,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4074269,"accession":"0001415889-25-003748","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-003748","line_url":"/filing/0001415889-25-003748#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":19.57,"price_display":"19.57","price_state":"stated","total_value":273980.0,"total_display":"273,980.00","total_whole":"273,980","shares_owned_after":81975.0,"shares_owned_after_display":"81,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":4174592,"accession":"0001415889-25-001496","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-001496","line_url":"/filing/0001415889-25-001496","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":18.24379642857143,"price_display":"18.24","price_state":"stated","total_value":255413.15,"total_display":"255,413.15","total_whole":"255,413","shares_owned_after":90652.0,"shares_owned_after_display":"90,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider","n_lines":2},{"id":2531146,"accession":"0001415889-24-029747","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029747","line_url":"/filing/0001415889-24-029747#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23017.0,"shares_display":"23,017","price_per_share":20.44,"price_display":"20.44","price_state":"stated","total_value":470467.48,"total_display":"470,467.48","total_whole":"470,467","shares_owned_after":95975.0,"shares_owned_after_display":"95,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":3238002,"accession":"0001415889-24-027354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-027354","line_url":"/filing/0001415889-24-027354#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":21.04,"price_display":"21.04","price_state":"stated","total_value":357680.0,"total_display":"357,680.00","total_whole":"357,680","shares_owned_after":102975.0,"shares_owned_after_display":"102,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":2279888,"accession":"0001415889-24-025374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-025374","line_url":"/filing/0001415889-24-025374#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":26.87,"price_display":"26.87","price_state":"stated","total_value":456790.0,"total_display":"456,790.00","total_whole":"456,790","shares_owned_after":109975.0,"shares_owned_after_display":"109,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider"},{"id":2662406,"accession":"0001415889-24-023954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023954","line_url":"/filing/0001415889-24-023954#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":24.99,"price_display":"24.99","price_state":"stated","total_value":437325.0,"total_display":"437,325.00","total_whole":"437,325","shares_owned_after":116975.0,"shares_owned_after_display":"116,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-23","filed_date":"2024-09-25","scope":"insider"},{"id":2662115,"accession":"0001415889-24-022560","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-022560","line_url":"/filing/0001415889-24-022560#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":26.91,"price_display":"26.91","price_state":"stated","total_value":470925.0,"total_display":"470,925.00","total_whole":"470,925","shares_owned_after":119911.0,"shares_owned_after_display":"119,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-29","scope":"insider"},{"id":2995664,"accession":"0001415889-24-006702","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-006702","line_url":"/filing/0001415889-24-006702#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001867899","owner_name":"Tessari Eben","owner_display_name":"Tessari Eben","owner_url":"/insider/0001867899","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1189.0,"shares_display":"1,189","price_per_share":22.03,"price_display":"22.03","price_state":"stated","total_value":26193.67,"total_display":"26,193.67","total_whole":"26,194","shares_owned_after":122847.0,"shares_owned_after_display":"122,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals International, plc","url":"/issuer/0001730430","role":"Officer (CHIEF OPERATING OFFICER)","n_filings":24,"first_seen":"2024-03-05","last_seen":"2025-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001867899","retrieved_at":"2026-08-24T05:34:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}